Edition:
United States

Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

86.54EUR
18 May 2018
Change (% chg)

-- (--)
Prev Close
€86.54
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
649,644
52-wk High
€93.82
52-wk Low
€76.42

Latest Key Developments (Source: Significant Developments)

Fresenius Medical Care Q4 Net Income 394 Mln Euros, Up 16 Pct At Constant Currency
Monday, 26 Feb 2018 04:56pm EST 

Feb 26 (Reuters) - Fresenius Medical Care ::SAYS FOR 2018, CO EXPECTS REVENUE GROWTH OF AROUND 8 PERCENT AT CONSTANT CURRENCY‍​.Q4 REVENUE 4.43 BILLION EUROS, YOY GROWTH 0%‍​.SAYS TARGETS 2017 ACHIEVED‍​.NET INCOME FOR THE FOURTH QUARTER OF 2017 INCREASED BY 16% AT CONSTANT CURRENCY TO EUR 394 MILLION.NET INCOME TO INCREASE 13 TO 15% AT CONSTANT CURRENCY INCLUDING RECURRING BENEFITS FROM U.S. TAX REFORM OF 140 TO 160 MILLION EUROS IN 2018.SAYS Q4 REVENUE GROWTH OF 8% AT CONSTANT CURRENCY.  Full Article

Fresenius Medical sets aside EUR200 mln for U.S. settlement talks
Monday, 26 Feb 2018 04:35pm EST 

Feb 26 (Reuters) - Fresenius Medical Care AG ::SAYS ‍ESTABLISHES PROVISION OF EUR 200 MILLION REGARDING ONGOING FCPA SETTLEMENT NEGOTIATIONS​.SAYS ‍PROVISION TAKES INTO ACCOUNT RECENT DEVELOPMENTS IN ONGOING SETTLEMENT NEGOTIATIONS WITH U.S. DEPARTMENT OF JUSTICE AND U.S. SECURITIES EXCHANGE COMMISSION​.SAYS ‍CHARGE ENCOMPASSES GOVERNMENT AGENCIES' CLAIMS FOR PROFIT DISGORGEMENT, AS WELL AS ACCRUALS FOR FINES AND/OR PENALTIES, CERTAIN LEGAL AND OTHER CONSULTANCY EXPENSES AND OTHER RELATED​.SAYS ‍SETTLEMENT NEGOTIATIONS ARE CONTINUING AND HAVE NOT YET ACHIEVED AN AGREEMENT-IN-PRINCIPLE; FAILURE TO REACH AGREEMENT REMAINS POSSIBLE​.  Full Article

Fresenius Medical Care Closes Divestment Of Shiel Medical Laboratory To Quest Diagnostics
Tuesday, 12 Dec 2017 08:03am EST 

Dec 12 (Reuters) - FRESENIUS MEDICAL CARE AG & CO KGAA ::DGAP-NEWS: FRESENIUS MEDICAL CARE CLOSES DIVESTMENT OF SHIEL MEDICAL LABORATORY TO QUEST DIAGNOSTICS.  Full Article

FMC Q3 impacted by natural disasters in North America
Thursday, 2 Nov 2017 02:00am EDT 

Nov 2 (Reuters) - FMC AG :‍Says Q3 sales up 3 pct at ‍4.336​ billion eur (+8 pct at constant currency).Says Q3 EBIT flat at ‍609​ million eur (+4 pct at constant currency).Says Q3 net income up 2 pct at ‍309 ​million eur.Says North American business impacted by natural disasters.Says ‍excluding effects from natural disasters, effects of agreement with U.S. Departments of Veterans Affairs and Justice, confirms its full-year outlook 2017​​.Says North America Care Coordination activities grow by 20% (+26 pct at constant currency), margin expands significantly to 7 pct​.Says ‍closing of NxStage deal is currently expected to occur in 2018​.Reuters poll average for FMC q3 net revenue was 4.41 billion eur, EBIT 611 million eur, net income 297 million eur.  Full Article

Quest Diagnostics to acquire Shiel Medical Laboratory from Fresenius Medical Care
Thursday, 28 Sep 2017 07:30am EDT 

Sept 28 (Reuters) - Quest Diagnostics Inc :Quest Diagnostics to acquire Shiel Medical Laboratory from Fresenius Medical Care.Quest Diagnostics Inc says financial terms were not disclosed..Says ‍transaction is structured as a purchase of assets.​.Quest Diagnostics Inc says transaction is expected to be completed in Q4 of 2017, subject to customary regulatory approvals.Quest Diagnostics - ‍Fresenius Medical Care's dialysis-related laboratory services business, Spectra Labs, is not affected by divestiture​.  Full Article

Eurotech wins order from Fresenius Medical Care for IoT project​
Friday, 8 Sep 2017 02:01am EDT 

Sept 8 (Reuters) - EUROTECH SPA ::‍DESIGN WIN WITH FRESENIUS MEDICAL CARE <<>> TO SUPPLY HARDWARE AND SOFTWARE BUILDING BLOCKS FOR THEIR IOT PROJECT​.NO FURTHER FINANCIAL DETAILS CAN BE DISCLOSED‍​.  Full Article

NxStage Medical posts Q2 loss of $0.03 per share
Monday, 7 Aug 2017 02:15am EDT 

Aug 7 (Reuters) - Nxstage Medical Inc :NxStage reports second quarter financial results.Q2 revenue $96.2 million versus I/B/E/S view $96.5 million.NxStage Medical - in light of acquisition agreement between Fresenius Medical Care and NxStage, NxStage is no longer providing financial guidance.Has canceled its previously announced conference call to discuss its financial results for Q2 of 2017.Qtrly loss per share $0.03.  Full Article

SEC charges four in insider case linked to healthcare policy leaks
Wednesday, 24 May 2017 10:31am EDT 

May 24 (Reuters) - U.S. SECURITIES AND EXCHANGE COMMISSION FILES CIVIL INSIDER TRADING CASE AGAINST DAVID BLASZCZAK, JORDAN FOGEL, THEODORE HUBER, CHRISTOPHER WORRALL IN CONNECTION WITH HEALTHCARE POLICY LEAKS -- COURT PAPERS:.  Full Article

Fresenius CEO says larger takeovers possible
Wednesday, 22 Feb 2017 05:42am EST 

Fresenius CEO : Says have looked at biosimilars and don't rule out becoming active in that area . Says doesn't see any major steps in terms of entering new hospital markets before 2019/2020 . Says is confident will present a new cfo soon . Says larger takeovers are possible Further company coverage: [FMEG.DE] ((frankfurt.newsroom@thomsonreuters.com; +49 69 7565 1270;)).  Full Article

FMC cannot yet assess impact of any changes to Obamacare - CEO
Wednesday, 22 Feb 2017 05:24am EST 

FMC CEO : Says tax cuts in the U.S. would be good for us . Says cannot yet say whether or to what extent changes to Obamacare will have an impact on the dialysis sector and FMC Further company coverage: [FMEG.DE] ((frankfurt.newsroom@thomsonreuters.com; +49 69 7565 1270;)).  Full Article

BRIEF-Fresenius Medical Care CEO: Looking To Pick-Up M&A Pace

* CEO TELLS Q1 ANALYST CALL WE ARE LOOKING TO BE MORE ACTIVE IN THE ACQUISITION ARENA; IT'S SMALL THINGS Further company coverage: (Reporting By Berlin Newsroom)